Barzolvolimab

CAT: 0804-HY-P99462-01Size: 1 mgDry Ice: YesHazardous: No
CAT#:0804-HY-P99462-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Barzolvolimab (CDX 0159) is a humanized anti-KIT IgG1 monoclonal antibody. Barzolvolimab specificity and potently inhibits KIT activation by SCF. Barzolvolimab can reduce skin mast cells and disease activity in chronic inducible urticaria[1].
CAS Number
[2438203-51-9]
Product Name Alternative
CDX-0159; CDX-0158
UNSPSC
12352203
Target
C-Kit
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/barzolvolimab.html
Purity
99.83
Solubility
H2O
Smiles
[Barzolvolimab]
Molecular Weight
(145.1 kDa)
References & Citations
[1]Terhorst-Molawi D, et, al. Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria. Allergy. 2022 Nov 16.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
MF-0099130-01Barzolvolimab
HY163016-01Research Grade Barzolvolimab
E55B0851Barzolvolimab (Reference antibody)
KDC83101Barzolvolimab ELISA Kit
ICH5374-20mgBarzolvolimab Biosimilar - Research Grade
A138314Barzolvolimab Biosimilar (Monoclonal, IgG1)
12-90067-100Anti-CD117 (barzolvolimab biosimilar) mAb
RA0443-01Barzolvolimab (Biosimilar Reference Antibody) (KIT)
A135559Barzolvolimab Biosimilar (Monoclonal, IgG1-kappa)
MBS1880965-01Biotinylated Anti-CD117 (barzolvolimab biosimilar) mAb

Popular Products